[Shock mediators and their antagonists as future therapeutic perspectives].
Lundsgaard-Hansen
P
P
Blauhut
B
B
Doran
J E
JE
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000502:physiology; D002118:Calcium / Q000502:physiology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005609:Free Radicals; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D010101:Oxygen Consumption; D010447:Peptide Hydrolases / Q000502:physiology; D010972:Platelet Activating Factor / Q000502:physiology; D012769:Shock / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D001095:Arachidonic Acids; D005609:Free Radicals; D007375:Interleukin-1; D010972:Platelet Activating Factor; D014409:Tumor Necrosis Factor-alpha; D016718:Arachidonic Acid; D010447:Peptide Hydrolases; D002118:Calcium
Schockmediatoren und ihre Antagonisten als therapeutische Zukunftsperspektiven.